{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/27/3281528/0/en/Clearmind-Medicine-Announces-Evaluation-of-its-Psychedelic-Based-Treatment-MEAI-for-Potential-FDA-Breakthrough-Therapy-Designation.html", "message": "News view counter 682406 successfully enlarged"}